These studies indicated that the keratinocytes-derived IL-1β may contribute to the melanocyte destruction under oxidative stress and NLRP3 inflammasome can be regarded as a potential drug target for the treatment of vitiligo. This evidence concerns the gene NLRP3 and vitiligo.